Bio-Techne
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Bio-Techne and other ETFs, options, and stocks.About TECH
Bio-Techne Corp. engages in the development, manufacture and sale of biotechnology reagents and instruments for the research and clinical diagnostic markets. It operates through the Protein Sciences, and Diagnostics and Genomics segments.
TECH Key Statistics
TECH News
In a welcome move, Bio-Techne (TECH) saw its Relative Strength Rating rise from 64 to 71 on Monday. X IBD's proprietary RS Rating measures technical performanc...
Bio-Techne Corporation (NASDAQ:TECH) defied analyst predictions to release its quarterly results, which were ahead of market expectations. The company beat expe...
Bio-Techne Corporation (NASDAQ:TECH) Q3 2024 Earnings Call Transcript May 1, 2024 Bio-Techne Corporation beats earnings expectations. Reported EPS is $0.48, ex...
Analyst ratings
87%
of 15 ratingsMore TECH News
Key Insights Using the 2 Stage Free Cash Flow to Equity, Bio-Techne fair value estimate is US$50.46 Bio-Techne is estimated to be 25% overvalued based on curr...
May 1(Reuters) - Bio-Techne on Wednesday beat third-quarter profit and revenue estimates, helped by better-than-expected demand for its cell and gene therapy pr...
Reports Q3 revenue $303.43M, consensus $292.19M. “I am proud of the remarkable execution of our Bio-Techne team under challenging end market conditions, which d...
The latest update is out from Bio-Techne (TECH). Bio-Techne Corporation has expanded its Board of Directors to eleven members and welcomed Dr. Judith Klimovsky...
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's balance sheet when you examine how risky...
